menthol has been researched along with Genetic Predisposition in 2 studies
Menthol: A monoterpene cyclohexanol produced from mint oils.
Excerpt | Relevance | Reference |
---|---|---|
"Novel pharmacotherapies for nicotine dependence include partial agonists for nicotinic receptors and nicotine vaccines." | 2.44 | Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction. ( Benowitz, NL, 2008) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Park, SJ | 1 |
Yi, B | 1 |
Lee, HS | 1 |
Oh, WY | 1 |
Na, HK | 1 |
Lee, M | 1 |
Yang, M | 1 |
Benowitz, NL | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Developing Genetic Education for Smoking Cessation[NCT01186016] | 103 participants (Actual) | Interventional | 2010-02-01 | Completed | |||
The Appeal and Impact of E-cigarettes in Smokers With Serious Mental Illness[NCT03050853] | 240 participants (Actual) | Interventional | 2017-03-01 | Completed | |||
Tobacco Treatment Outreach to Reduce Disparities for Primary Care Populations[NCT01156610] | 706 participants (Actual) | Interventional | 2011-11-30 | Completed | |||
Smokers' Response to Nicotine Dependence Genotyping[NCT01780038] | 24 participants (Actual) | Interventional | 2012-11-14 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Knowledge of genetic contributions to smoking. Name of Scale: Genetic Knowledge Test (9 items). Minimum/Maximum Scores: 0-9. Higher score means better outcome. (NCT01186016)
Timeframe: One week after completion of the two Educational Sessions (GES or NES). Educational sessions occurred over two weeks.
Intervention | score on a scale (Mean) | |
---|---|---|
Baseline | End of Educational Sessions | |
Genetic Education Session (GES) | 5.25 | 7.04 |
Nutrition Education Session (NES) | 3.73 | 4.03 |
Self-efficacy for Quitting/Resisting Smoking. Self-efficacy/Temptation Scale (Velicer, DiClemente, Rossi & Prochaska, 1990) Total Score. Scores range from 1 to 5, with higher scores indicating greater self-efficacy. Source: Velicer, W.F., DiClemente, C.C., Rossi, J.S., & Prochaska, J.O. (1990). Relapse situations and self-efficacy: An integrative model. Addictive Behaviors, 15, 271-283. (NCT01186016)
Timeframe: Six weeks after the baseline data collection, which was the end of the Smoking Cession Sessions.
Intervention | score on a scale (Mean) | ||
---|---|---|---|
Baseline | End of Educational Sessions | End of Smoking Cessation Sessions | |
Genetic Education Session (GES) | 3.93 | 3.80 | 2.73 |
Nutrition Education Session (NES) | 3.99 | 3.86 | 2.57 |
2 reviews available for menthol and Genetic Predisposition
Article | Year |
---|---|
To quit or not: Vulnerability of women to smoking tobacco.
Topics: Behavior, Addictive; Epigenesis, Genetic; Female; Genetic Predisposition to Disease; Hormones; Human | 2016 |
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American | 2008 |
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American | 2008 |
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American | 2008 |
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American | 2008 |
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American | 2008 |
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American | 2008 |
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American | 2008 |
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American | 2008 |
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American | 2008 |
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American | 2008 |
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American | 2008 |
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American | 2008 |
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American | 2008 |
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American | 2008 |
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American | 2008 |
Clinical pharmacology of nicotine: implications for understanding, preventing, and treating tobacco addiction.
Topics: Antidepressive Agents; Aryl Hydrocarbon Hydroxylases; Asian; Benzazepines; Black or African American | 2008 |